The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.

Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.

Investigational New Drugs cuts across all the usual lines or subdisciplines, providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development.

100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Editor-in-chief
  • Eric K. Rowinsky
Publishing model
Hybrid. Open Choice – What is this?
Impact
Impact factor: 2.663 (2018)
Five year impact factor: 2.811 (2018)
Speed
Submission to first decision: 21 days
Usage
Downloads: 162,982 (2018)

Articles

Subscribe

Subscription
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2019

Advertisement

About this journal

Electronic ISSN
1573-0646
Print ISSN
0167-6997
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. Chemical Abstracts Service (CAS)
  4. Current Contents/ Life Sciences
  5. Current Contents/Clinical Medicine
  6. EBSCO Biomedical Reference Collection
  7. EBSCO CINAHL
  8. EBSCO Discovery Service
  9. EMBASE
  10. Elsevier Biobase
  11. Gale
  12. Gale Academic OneFile
  13. Gale InfoTrac
  14. Google Scholar
  15. Institute of Scientific and Technical Information of China
  16. Japanese Science and Technology Agency (JST)
  17. Journal Citation Reports/Science Edition
  18. Medline
  19. Naver
  20. OCLC WorldCat Discovery Service
  21. Pathway Studio
  22. ProQuest ABI/INFORM
  23. ProQuest Agricultural & Environmental Science Database
  24. ProQuest Biological Science Database
  25. ProQuest Biotechnology Research Abstracts
  26. ProQuest Business Premium Collection
  27. ProQuest Central
  28. ProQuest Consumer Health
  29. ProQuest Engineering
  30. ProQuest Environmental Science
  31. ProQuest Health & Medical Collection
  32. ProQuest Health Research Premium Collection
  33. ProQuest Materials Science and Engineering Database
  34. ProQuest Medical Database
  35. ProQuest Natural Science Collection
  36. ProQuest Nursing & Allied Health Database
  37. ProQuest Pharma Collection
  38. ProQuest SciTech Premium Collection
  39. ProQuest Technology Collection
  40. ProQuest-ExLibris Primo
  41. ProQuest-ExLibris Summon
  42. Reaxys
  43. SCImago
  44. SCOPUS
  45. Science Citation Index
  46. Science Citation Index Expanded (SciSearch)
  47. Semantic Scholar
Copyright information

Rights and permissions

Springer Nature policies

© Springer Science+Business Media, LLC, part of Springer Nature